PTGS2 and breast cancer: 3.5. Effects of γ-Tocotrienol, Rosiglitazone, and GW9662 Treatment Alone or in Combination on COX-2 and PGDS Protein Expression and mRNA Levels in PPARγ Negative +SA Mammary Tumor Cells